Marché américain du traitement de l’hyperparathyroïdie secondaire 2021 par fabricants, régions, type et application, prévisions jusqu’en 2026

US Secondary Hyperparathyroidism Treatment Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis Industry Forecast 2021 To 2027 is latest report published on “Global U.S Secondary Hyperparathyroidism Treatment Market” by Fortune Business Insights. The global robotaxi market size was USD 4.34 billion in 2018. The global impact of COVID-19 pandemic has been unprecedented and staggering, with robotaxi witnessing a positive demand across all regions amid the pandemic. Based on our analysis, the global commercial vehicle market size is projected to reach USD 7.06 billion by the end of 2026. The increasing IT sector and rapid industrialization across the globe will emerge in favor of market growth.

To Understand U.S Secondary Hyperparathyroidism Treatment Key Trends, Download Sample Report:

www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664

U.S Secondary Hyperparathyroidism Treatment Top Companies Analyzed in the report:

  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Genzyme Corporation (Sanofi)
  • AbbVie Inc.
  • Cipla Inc.
  • Reddy’s Laboratories Ltd.
  • OPKO Health, Inc.
  • Other Prominent Players

Rising Prevalence Of Chronic Kidney Disease Will Stimulate Growth 

The increasing prevalence of chronic kidney disease among geriatric population as well as general population will enable the growth of the secondary hyperparathyroidism treatment market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 15% of U.S adults, which, is, 37 million people are estimated to have chronic kidney disease. Additionally, CKD is found more common in people aged 65 years or older than in people aged 45-64 years. The rising cases of renal disease and increasing patient pool will have a significant impact on the market. The increasing cost burden for the treatment of secondary hyperparathyroidism will further encourage growth of the market. In addition, the launch of generic form of Cinacalcet hydrochloride tablets will bode well for the secondary hyperparathyroidism treatment market. For instance, Cipla Inc. and its subsidiary Cipla USA Inc. announced the launch of a generic form of Cinacalcet hydrochloride tablets in USA. Moreover, Amgen Inc. announced the USFDA approval of Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD). The approval for Parsabiv will also aid the growth of the market during the forecast period.

Emerging Guidelines By Government Authorities Will Boost Growth

The increasing government initiatives for improvising secondary hyperparathyroidism management will create growth opportunities for the secondary hyperparathyroidism treatment market. The aim of SHPT treatment is to manage the biochemical markers of bone and mineral metabolism, which are directly linked to cardiovascular events and bone fractures by extensive epidemiologic evidence. International & national organizations in the U.S. and working groups such as the National Kidney Foundation have published various clinical guidance documents to encourage best practices in managing SHPT. Furthermore, increasing awareness about SHPT in physicians, as well as clinical specialists, have improved the treatment regimen for its management. The improvement in earlier identification and assessment of SHPT for mineral metabolism in CKD & ESRD will have a positive impact on secondary hyperparathyroidism treatment market growth. The reduction in associated complications for the management of SHPT is expected to accelerate growth of the market during the forecast period.

Key questions answered in the report:

  • What will the market growth rate of U.S Secondary Hyperparathyroidism Treatment market in 2027?
  • What are the key factors driving the global U.S Secondary Hyperparathyroidism Treatment market?
  • Who are the key manufacturers in U.S Secondary Hyperparathyroidism Treatment market space?
  • What are the market opportunities, market risk and market overview of the U.S Secondary Hyperparathyroidism Treatment market?
  • What are sales, revenue, and price analysis of top manufacturers of U.S Secondary Hyperparathyroidism Treatment market?
  • Who are the distributors, traders and dealers of U.S Secondary Hyperparathyroidism Treatment market?
  • What are the U.S Secondary Hyperparathyroidism Treatment market opportunities and threats faced by the vendors in the global U.S Secondary Hyperparathyroidism Treatment industry?
  • Quelles sont les ventes, les revenus et l’analyse des prix par types et applications du marché américain Traitement de l’hyperparathyroïdie secondaire?
  • Quelles sont les ventes, les revenus et l’analyse des prix par régions de l’industrie américaine Traitement secondaire de l’hyperparathyroïdie ?

Avez-vous une question ? Demandez à nos experts :

www.fortunebusinessinsights.com/enquiry/speak-to-analyst/us-secondaire-hyperparathyroïdie-shpt-traitement-market-101664

Table des matières:

  1. introduction

1.1. Portée de la recherche

1.2. Segmentation du marché

1.3. Méthodologie de recherche

1.4. Définitions et hypothèses

  1. Résumé
  2. Dynamique du marché

3.1. Facteurs de marché

3.2. Contraintes du marché

  1. Idées clés

4.1 Fusions, acquisitions et partenariats

4.2 Analyse de croissance et de pénétration

4.3 Analyse des cinq forces de Porter

4.4 Analyse PEST

4.5 Développements technologiques dans le traitement secondaire de l’hyperparathyroïdie aux États-Unis

4.6 Analyse d’impact du Covid-19

A continué…

À propos de nous:

Fortune Business Insights™ offre une analyse d’entreprise experte et des données précises, aidant les organisations de toutes tailles à prendre des décisions opportunes. Nous adaptons des solutions innovantes à nos clients, les aidant à relever les défis propres à leurs entreprises. Notre objectif est de fournir à nos clients des informations globales sur le marché, en leur donnant un aperçu granulaire du marché sur lequel ils opèrent.

Nos rapports contiennent un mélange unique d’informations tangibles et d’analyses qualitatives pour aider les entreprises à atteindre une croissance durable. Notre équipe d’analystes et de consultants expérimentés utilise des outils et des techniques de recherche de pointe pour compiler des études de marché complètes, entrecoupées de données pertinentes.

Nous contacter:

Fortune Business Insights Pvt. Ltd.

308, Quartier général suprême,

Enquête n° 36, Baner,

Autoroute Pune-Bangalore,

Pune -411045, Maharashtra, Inde.

États-Unis : +1 424 253 0390

Royaume-Uni : +44 2071 939123

APAC : +91 744 740 1245